Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson

• Sonja Hatz ,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: Sonja.Hatz@merckgroup.com

  Affiliation Merck KGaA, Frankfurter Straße, Darmstadt, Germany

  http://orcid.org/0000-0002-1350-131X

  ⨯
• Scott Spangler,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation IBM Watson Health, Almaden, California, United States of America

  ⨯
• Andrew Bender,

  Roles Conceptualization, Formal analysis

  Affiliation EMD Serono, Middlesex Turnpike, Billerica, United States of America

  ⨯
• Matthew Studham,

  Roles Conceptualization, Formal analysis

  Affiliation EMD Serono, Middlesex Turnpike, Billerica, United States of America

  ⨯
• Philipp Haselmayer,

  Roles Conceptualization

  Affiliation Merck KGaA, Frankfurter Straße, Darmstadt, Germany

  ⨯
• Alix M. B. Lacoste,

  Roles Writing – original draft

  Affiliation IBM Watson Health, New York, New York, United States of America

  ⨯
• Van C. Willis,

  Roles Writing – review & editing

  Affiliation IBM Watson Health, Cambridge, Massachusetts, United States of America

  ⨯
• Richard L. Martin,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation IBM Watson Health, Cambridge, Massachusetts, United States of America

  http://orcid.org/0000-0001-9858-2608

  ⨯
• Harsha Gurulingappa,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Merck KGaA, Frankfurter Straße, Darmstadt, Germany

  ⨯
• Ulrich Betz

  Roles Conceptualization

  Affiliation Merck KGaA, Frankfurter Straße, Darmstadt, Germany

  ⨯